SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Monica Verdoia, Chiara Sartori, Patrizia Pergolini, Matteo Nardin, Roberta Rolla, Lucia Barbieri, Alon Schaffer, Paolo Marino, Giorgio Bellomo, Harry Suryapranata, Giuseppe De Luca, Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation, Vascular Pharmacology, 2016, 77, 48

    CrossRef

  2. 2
    Monica Verdoia, Alon Schaffer, Ettore Cassetti, Gabriella Di Giovine, Paolo Marino, Harry Suryapranata, Giuseppe De Luca, Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study, Journal of Thrombosis and Thrombolysis, 2015, 39, 4, 459

    CrossRef

  3. 3
    Monica Verdoia, Alon Schaffer, Lucia Barbieri, Harry Suryapranata, Giuseppe De Luca, Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials, Thrombosis Research, 2015, 135, 5, 902

    CrossRef

  4. 4
    E. P. Navarese, F. Andreotti, M. Kołodziejczak, V. Schulze, G. Wolff, S. Dias, B. Claessen, M. Brouwer, G. Tarantini, S. Iliceto, M. Brockmeyer, M. Kowalewski, Y. Lin, J. Eikelboom, G. Musumeci, L. Lee, G. Y. H. Lip, M. Valgimigli, S. Berti, M. Kelm, Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes, Thrombosis and Haemostasis, 2015, 114, 5, 933

    CrossRef

  5. 5
    Eliano Pio Navarese, Volker Schulze, Felicita Andreotti, Mariusz Kowalewski, Michalina Kołodziejczak, David E. Kandzari, Tienush Rassaf, Bartosz Gorny, Maximilian Brockmeyer, Christian Meyer, Sergio Berti, Jacek Kubica, Malte Kelm, Marco Valgimigli, Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome, JACC: Cardiovascular Interventions, 2015, 8, 1, 201

    CrossRef

  6. 6
    M. Verdoia, A. Schaffer, H. Suryapranata, G. De Luca, Effects of HDL-modifiers on cardiovascular outcomes: A meta-analysis of randomized trials, Nutrition, Metabolism and Cardiovascular Diseases, 2015, 25, 1, 9

    CrossRef

  7. 7
    Monica Verdoia, Alon Schaffer, Lucia Barbieri, Gabriella Di Giovine, Paolo Marino, Harry Suryapranata, Giuseppe De Luca, Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients, Journal of Diabetes and its Complications, 2015, 29, 4, 517

    CrossRef

  8. 8
    Gabriella Di Giovine, Monica Verdoia, Lucia Barbieri, Alon Schaffer, Gianluca Aimaretti, Giorgio Bellomo, Paolo Marino, Harry Suryapranata, Fabiola Sinigaglia, Giuseppe De Luca, Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study, Diabetes Research and Clinical Practice, 2015, 109, 3, 541

    CrossRef

  9. 9
    Giuseppe De Luca, Maurits T. Dirksen, Henning Kelbæk, Leif Thuesen, Marteen A. Vink, Christoph Kaiser, Tania Chechi, Gaia Spaziani, Emilio Di Lorenzo, Harry Suryapranata, Gregg W. Stone, Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials, Journal of Thrombosis and Thrombolysis, 2015, 39, 1, 101

    CrossRef

  10. 10
    L. Barbieri, M. Verdoia, A. Schaffer, E. Cassetti, P. Marino, H. Suryapranata, G. De Luca, Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI, Nutrition, Metabolism and Cardiovascular Diseases, 2015, 25, 2, 181

    CrossRef

  11. 11
    Monica Verdoia, Alon Schaffer, Lucia Barbieri, Fabiola Sinigaglia, Paolo Marino, Harry Suryapranata, Giuseppe De Luca, Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions, Atherosclerosis, 2014, 236, 1, 169

    CrossRef

  12. 12
    L. Lee, C. Varma, Lessons from primary PCI practice for the next decade, Heart, 2014, 100, 21, 1667

    CrossRef

  13. 13
    Lucia Barbieri, Monica Verdoia, Alon Schaffer, Ettore Cassetti, Gabriella Di Giovine, Paolo Marino, Harry Suryapranata, Giuseppe De Luca, Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention, Diabetes Research and Clinical Practice, 2014, 106, 3, 458

    CrossRef

  14. 14
    Alon Schaffer, Monica Verdoia, Ettore Cassetti, Paolo Marino, Harry Suryapranata, Giuseppe De Luca, Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study, Thrombosis Research, 2014, 134, 2, 288

    CrossRef

  15. 15
    Lucia Barbieri, Monica Verdoia, Alon Schaffer, Matteo Nardin, Paolo Marino, Giuseppe De Luca, The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials, Journal of Thrombosis and Thrombolysis, 2014, 38, 4, 493

    CrossRef

  16. 16
    Vikas Singh, Mauricio G. Cohen, Therapy in ST-elevation myocardial infarction: reperfusion strategies, pharmacology and stent selection, Current Treatment Options in Cardiovascular Medicine, 2014, 16, 5

    CrossRef

  17. 17
    Dennis T. L. Wong, Rishi Puri, Peter J. Psaltis, Stephen G. Worthley, Matthew I. Worthley, Acute ST-segment myocardial infarction—Evolution of treatment strategies, World Journal of Cardiovascular Diseases, 2013, 03, 09, 551

    CrossRef

  18. 18
    I. Ahrens, C. Bode, A. Zirlik, Anticoagulation during and after acute coronary syndrome, Hämostaseologie, 2013, 34, 1, 72

    CrossRef

  19. 19
    Gabriel Steg, Stefan K. James, Dan Atar, Luigi P. Badano, Carina Blomstrom Lundqvist, Michael A. Borger, Carlo di Mario, Kenneth Dickstein, Gregory Ducrocq, Francisco Fernández-Avilés, Anthony H. Gershlick, Pantaleo Giannuzzi, Sigrun Halvorsen, Kurt Huber, Peter Juni, Adnan Kastrati, Juhani Knuuti, Mattie J. Lenzen, Kenneth W. Mahaffey, Marco Valgimigli, Arnoud van’t Hof, Petr Widimsky, Doron Zahger, Jeroen J. Bax, Helmut Baumgartner, Claudio Ceconi, Veronica Dean, Christi Deaton, Robert Fagard, Christian Funck-Brentano, David Hasdai, Arno Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Theresa McDonagh, Cyril Moulin, Bogdan A. Popescu, Zeljko Reiner, Udo Sechtem, Per Anton Sirnes, Michal Tendera, Adam Torbicki, Alec Vahanian, Stephan Windecker, Felicity Astin, Karin Astrom-Olsson, Andrzej Budaj, Peter Clemmensen, Jean-Philippe Collet, Keith A. Fox, Ahmet Fuat, Olivija Gustiene, Christian W. Hamm, Petr Kala, Patrizio Lancellotti, Aldo Pietro Maggioni, Béla Merkely, Franz-Josef Neumann, Massimo F. Piepoli, Frans van de Werf, Freek Verheugt, Lars Wallentin, Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST, Revista Española de Cardiología, 2013, 66, 1, 53.e1

    CrossRef

  20. 20
    S. Birkmeier, H. Thiele, R. Dörr, Management des akuten ST-Strecken-Hebungsinfarktes, Herz, 2013, 38, 8, 889

    CrossRef

  21. 21
    R. De Caterina, S. Husted, L. Wallentin, F. Andreotti, H. Arnesen, F. Bachmann, C. Baigent, K. Huber, J. Jespersen, S. D. Kristensen, G. Y. H. Lip, J. Morais, L. H. Rasmussen, A. Siegbahn, F. W. A. Verheugt, J. I. Weitz, Parenteral anticoagulants in heart disease: Current status and perspectives (Section II), Thrombosis and Haemostasis, 2013, 109, 5, 769

    CrossRef

  22. 22
    Jolanta M. Siller-Matula, Marcel Francesconi, Cornelia Dechant, Bernd Jilma, Gerald Maurer, Georg Delle-Karth, Ghazaleh Gouya, Katharina Ruzicka, Andrea Podczeck-Schweighofer, Günter Christ, Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study, International Journal of Cardiology, 2013, 167, 5, 2018

    CrossRef

  23. 23
    Giuseppe De Luca, Guido Parodi, Roberto Sciagrà, Benedetta Bellandi, Monica Verdoia, Ruben Vergara, Angela Migliorini, Renato Valenti, David Antoniucci, Relation of Gender to Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty, The American Journal of Cardiology, 2013, 111, 7, 936

    CrossRef

  24. 24
    Johanne Silvain, Gilles Montalescot, Anticoagulant for primary percutaneous coronary intervention – the last dance for unfractionated heparin?, Archives of Cardiovascular Diseases, 2012, 105, 5, 259

    CrossRef

  25. 25
    P. G. Steg, S. K. James, D. Atar, L. P. Badano, C. B. Lundqvist, M. A. Borger, C. Di Mario, K. Dickstein, G. Ducrocq, F. Fernandez-Aviles, A. H. Gershlick, P. Giannuzzi, S. Halvorsen, K. Huber, P. Juni, A. Kastrati, J. Knuuti, M. J. Lenzen, K. W. Mahaffey, M. Valgimigli, A. van't Hof, P. Widimsky, D. Zahger, J. J. Bax, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, A. Torbicki, A. Vahanian, S. Windecker, D. Hasdai, F. Astin, K. Astrom-Olsson, A. Budaj, P. Clemmensen, J.-P. Collet, K. A. Fox, A. Fuat, O. Gustiene, C. W. Hamm, P. Kala, P. Lancellotti, A. P. Maggioni, B. Merkely, F.-J. Neumann, M. F. Piepoli, F. Van de Werf, F. Verheugt, L. Wallentin, ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), European Heart Journal, 2012, 33, 20, 2569

    CrossRef

  26. 26
    Biotechnology of Plasma Proteins, 2012,

    CrossRef

  27. 27
    N. DUSCHEK, M. VAFAIE, E. SKRINJAR, K. HIRSCH, T. WALDHÖR, W. HÜBL, W. BERGMAYR, P. KNOEBL, A. ASSADIAN, Comparison of enoxaparin and unfractionated heparin in endovascular interventions for the treatment of peripheral arterial occlusive disease: a randomized controlled trial, Journal of Thrombosis and Haemostasis, 2011, 9, 11